CLPT - Company ID 0001285550
ClearPoint Neuro, Inc. trades as CLPT. In its fiscal 2025 annual report the company posted revenue of $36.97M, up 17.8% from the prior year and net income of -$25.54M. This page tracks ClearPoint Neuro, Inc. through 1,002 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years ClearPoint Neuro, Inc.'s revenue grew from $5.75M to $36.97M, a compound annual growth rate of 23.0%. Net profit margin expanded from -140.4% to -69.1% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
The largest companies sharing ClearPoint Neuro, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
ClearPoint Neuro, Inc. reported revenue of $36.97M for fiscal year 2025, an increase of 17.8% year over year.
In its latest fiscal year ClearPoint Neuro, Inc. reported a net loss of $25.54M.